Efficacy of NS5A inhibitors against unusual and potentially difficult-to-treat HCV subtypes commonly found in sub Saharan Africa and South East Asia

Efficacy of NS5A inhibitors against unusual and potentially difficult-to-treat HCV subtypes commonly found in sub Saharan Africa and South East Asia

<br><strong>Background Aims: </strong>The efficacy of NS5A inhibitors against several less common subtypes of hepatitis C virus (HCV) is poorly characterised. Some subtypes including 3b, 3g, 6u and 6v commonly harbour amino acid residues as wild type in NS5A that may confer resista...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Nguyen, D, Smith, D, Vaughan-Jackson, A, Magri, A, Barnes, E, Simmonds, P, STOP-HCV Consortium
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Elsevier 2020

Gelijkaardige items

Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors
door: Smith, D, et al.
Gepubliceerd in: (2018)

Identification of NS2 determinants stimulating intrinsic HCV NS2 protease activity.
door: Olaf Isken, et al.
Gepubliceerd in: (2022-06-01)

Prevalence of HCV genotypes and subtypes in Southeast Asia: A systematic review and meta-analysis.
door: Ahmad Adebayo Irekeola, et al.
Gepubliceerd in: (2021-01-01)

A conserved NS3 surface patch orchestrates NS2 protease stimulation, NS5A hyperphosphorylation and HCV genome replication.
door: Olaf Isken, et al.
Gepubliceerd in: (2015-03-01)

Analysis of HCV in South East Asia
door: Barnes, E, et al.
Gepubliceerd in: (2007)

Direct binding of ledipasvir to HCV NS5A: mechanism of resistance to an HCV antiviral agent.
door: Hyock Joo Kwon, et al.
Gepubliceerd in: (2015-01-01)

HCV NS3 inhibitors resistance mutations in the telaprevir started Turkish patients with chronic HCV
door: M. Sayan, et al.
Gepubliceerd in: (2014-04-01)

Correction: A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication.
door: Olaf Isken, et al.
Gepubliceerd in: (2016-01-01)

The Future of HCV Therapy: NS4B as an Antiviral Target
door: Hadas Dvory-Sobol, et al.
Gepubliceerd in: (2010-11-01)

Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: A systematic review
door: Walker, A, et al.
Gepubliceerd in: (2018)

Induction of intrahepatic HCV NS4B, NS5A and NS5B-specific cellular immune responses following peripheral immunization.
door: Krystle A Lang Kuhs, et al.
Gepubliceerd in: (2012-01-01)

Comparison of next generation sequencing technologies for the comprehensive assessment of full-length hepatitis C viral genomes
door: Ip, C, et al.
Gepubliceerd in: (2016)

Correction: Induction of Intrahepatic HCV NS4B, NS5A and NS5B-Specific Cellular Immune Responses following Peripheral Immunization
Gepubliceerd in: (2013-01-01)

Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection
door: Lappalainen Maija, et al.
Gepubliceerd in: (2009-06-01)

Correction: Induction of Intrahepatic HCV NS4B, NS5A and NS5B-Specific Cellular Immune Responses following Peripheral Immunization.
door: Krystle A. Lang Kuhs, et al.
Gepubliceerd in: (2013-01-01)

HCV evolution and positive selection sites of HCV NS5B region among intravenous drug users in Guangdong
door: Min WANG, et al.
Gepubliceerd in: (2022-06-01)

Identification of 19 novel Hepatitis C virus subtypes - further expanding HCV classification
door: Hedskog, C, et al.
Gepubliceerd in: (2019)

A study on the relationship between HCV NS3 and endogenous IRF-3
door: Hong-Ping Liang, et al.
Gepubliceerd in: (2018-07-01)

In silico analysis of the effect of HCV genotype-specific polymorphisms in Core, NS3, NS5A, and NS5B proteins on T-cell epitope processing and presentation
door: Samina Baig, et al.
Gepubliceerd in: (2025-01-01)

A revisit into the Den2 NS2B/NS3 virus protease homology model: Structural verification and comparison with crystal structure of HCV NS3/4A and Den2 NS3
door: Lee, Y.K., et al.
Gepubliceerd in: (2006)

The NS5A domain II of HCV : conservation of intrinsic disorder in several genotypes
door: Hanoulle, Xavier, et al.
Gepubliceerd in: (2012)

Reexamining Povarov Reaction’s Scope and Limitation in the Generation of HCV-NS4A Peptidomimetics
door: Maan T. Khayat, et al.
Gepubliceerd in: (2022-01-01)

Perilipin 5 alleviates HCV NS5A-induced lipotoxic injuries in liver
door: Jin Zhang, et al.
Gepubliceerd in: (2019-04-01)

Potent HCV NS3 Protease Inhibition by a Water-Soluble Phyllanthin Congener
door: Uma Reddy B, et al.
Gepubliceerd in: (2020-05-01)

A Surface Plasmon Resonance Method to Study HCV NS5B Inhibitors
door: Melanie Wong, et al.
Gepubliceerd in: (2014-02-01)

Natural polymorphisms in the resistance associated sites of HCV-G1 NS5B domain and correlation with geographic origin of HCV isolates
door: Sabrina Bagaglio, et al.
Gepubliceerd in: (2018-09-01)

'Locked jaw' – An unusual unanticipated difficult airway
door: Ananda Bangera, et al.
Gepubliceerd in: (2022-01-01)

Renal malokaplakia: An unusual disease of difficult diagnosis
door: Justinico Castro, José Armando, et al.
Gepubliceerd in: (2018-07-01)

Inference of Host–Pathogen Interaction Matrices from Genome-Wide Polymorphism Data
door: Märkle, H, et al.
Gepubliceerd in: (2024)

Inference of Host–Pathogen Interaction Matrices from Genome-Wide Polymorphism Data
door: Märkle, H, et al.
Gepubliceerd in: (2024)

HCV core residues critical for infectivity are also involved in core-NS5A complex formation.
door: Katarzyna Gawlik, et al.
Gepubliceerd in: (2014-01-01)

HCV antiviral therapy in injection drug users: difficult to treat or easy to cure?
door: Marcello Persico, et al.
Gepubliceerd in: (2015-05-01)

VIROLOGICAL RESPONSES TO COMBINATION THERAPY IN PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1B ARE RELATED WITH DYNAMIC OF HCV-NS-SPECIFIC T CELL RESPONSES
door: Zhang, Y, et al.
Gepubliceerd in: (2010)

NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients
door: Maria Concetta Bellocchi, et al.
Gepubliceerd in: (2019-07-01)

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b
door: Asad Sultan, et al.
Gepubliceerd in: (2011-06-01)

Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking
door: Tomasz M. Karpiński, et al.
Gepubliceerd in: (2023-06-01)

Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships
door: Hu K, et al.
Gepubliceerd in: (2020-02-01)

Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain.
door: Assaf Shapira, et al.
Gepubliceerd in: (2011-01-01)

New insights regarding HCV-NS5A structure/function and indication of genotypic differences
door: Yamasaki Lilian HT, et al.
Gepubliceerd in: (2012-01-01)

Probing of exosites leads to novel inhibitor scaffolds of HCV NS3/4A proteinase.
door: Sergey A Shiryaev, et al.
Gepubliceerd in: (2012-01-01)